3rd EPIC- XS Webinar on Clinical Proteomics

Back to list May 07, 2021

3rd EPIC- XS Webinar on Clinical Proteomics



On 17 June 2021, the 3rd EPIC- XS Webinar entitled on Clinical Proteomics will take place.

The European Proteomics Infrastructure Consortium providing Access (EPIC-XS) consists of a unified network of experienced access providers and research groups who share a common goal: to facilitate the development and sustainability of proteomics exploration to all life science researchers within the European Union. The initiative is coordinated by the Utrecht University.

The Webinar will include:

  • A first series of talks on advances on Proteomics and Epi-proteomics profiling of clinical samples.
  • A second session on Clinical Phosphoproteomics and cancer proteomics.
  • A final round table on current perspective and challenges in clinical proteomics.

The past 2021 Webinars were a great success; don’t miss the event and join the 3rd EPIC-XS Webinar on Clinical Proteomics!

Registration is free and open until 11 June 2021, click here to sign up.

For more information, visit the EPIC-XS website and follow EPIC-XS on Twitter.

EPIC-XS has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 823839.





June 17th, 2021, 15:40-18:00

On Zoom


15.40 - 15.45   Welcome by Chairperson, Tiziana Bonaldi

15:45-16:45   Advances on Proteomics and Epi-proteomics profiling of clinical samples

First series of talks from the European Institute of Oncology IEO- Milano (Tiziana Bonaldi’s lab)- Milano, CNIO- Madrid (Javier Munoz’ lab), and the Imperial College- London (Luca Magnani’s lab)


Chair: Tiziana Bonaldi European Institute of Oncology (IEO)

15:45-16:00    Histone PTM and variant analysis from low abundance clinical samples - Roberta Noberini (IEO)

16:00-16:15   Revisiting the protein content of extracellular vesicles - Javier Munoz (CNIO)

16:15-16:30    Epigenomics to capture non-genetic adaptive strategies of dormant cells - Luca Magnani (Imperial College)

16:30-16:45    Q&A with the 3 speakers, moderated by Tiziana Bonaldi

16:45-16:50    Coffee break

16:50-18:00    Clinical Phosphoproteomics and new perspectives in cancer proteomics

Second series of talks from Pepscope - Utrecht, University of Copenhagen UCPH - Copenhagen (Jesper Olsen’s lab), and the Baylor College of Medicine BCM Houston, TX (Matthew Ellis’s lab, CPTAC)


Chair: Maarten Altelaar University of Utrecht

16:50-17:05    Direct kinase and pathway activity profling in breast cancer patients - Erik de Graaf (Pepscope, Utrecht)

17:05-17:20    Unraveling the phosphoproteome of patient-derived ovarian cancer stem cells - Giulia Franciosa (UCPH)

17:20-17:40    Proteogenomics of Breast Cancer: Clinical implication - Matthew Ellis (BCM, CPTAC)

17:40-17:55    Q&A with the 3 speakers, moderated by Maarten Altelaar

17.55-18:00    Wrap up and conclusions by Tiziana Bonaldi

Meeting Program

Our site uses cookies for better browsing usability and statistics on its use. If you want to learn more, or refuse consent to all or some cookies, click here.